CNO Financial Group Reports First Quarter 2019 Results
"For the third consecutive quarter, CNO delivered strong production results in all three of our businesses," said
Highlights
- First-year collected premiums were up 18% from 1Q18
- All health benefit ratios were within - or more favorable - than provided guidance
- Returned
$63.4 million to shareholders in the form of share repurchases ($47.0 million ) and dividends ($16.4 million ) - Book value per common share was
$23.99 atMarch 31, 2019 - Completed Web Benefits Design acquisition (Read the press release here)
Quarterly Operating Results
|
Three months ended |
|||||||
|
|
|||||||
|
2019 |
2018 |
||||||
|
(Dollars in millions, |
|||||||
|
Net operating income (1) |
$ |
65.8 |
$ |
73.9 |
|||
|
Net realized investment gains (losses) from sales and impairments (net of related amortization) |
(.7) |
.5 |
|||||
|
Net change in market value of investments recognized in earnings |
16.6 |
(15.7) |
|||||
|
Fair value changes in embedded derivative liabilities (net of related amortization) |
(29.6) |
25.1 |
|||||
|
Fair value changes related to agent deferred compensation plan |
(5.3) |
— |
|||||
|
Other |
1.2 |
3.3 |
|||||
|
Non-operating income (loss) before taxes |
(17.8) |
13.2 |
|||||
|
Income tax expense (benefit) on non-operating income |
(3.8) |
2.8 |
|||||
|
Net non-operating income (loss) |
(14.0) |
10.4 |
|||||
|
Net income |
$ |
51.8 |
$ |
84.3 |
|||
|
Per diluted share: |
|||||||
|
Net operating income |
$ |
.41 |
$ |
.44 |
|||
|
Net realized investment gains (losses) from sales and impairments (net of related amortization and taxes) |
— |
— |
|||||
|
Net change in market value of investments recognized in earnings (net of taxes) |
.08 |
(.07) |
|||||
|
Fair value changes in embedded derivative liabilities (net of related amortization and taxes) |
(.15) |
.12 |
|||||
|
Fair value changes related to agent deferred compensation plan (net of taxes) |
(.03) |
— |
|||||
|
Other |
.01 |
.01 |
|||||
|
Net income |
$ |
.32 |
$ |
.50 |
|||
Please refer to our 1Q2019 Quarterly Financial Supplement for additional information related to the Company's financial and reporting results for the quarter ended
Significant Items Impacting Net Operating Income
|
Three months ended |
|||||||||||||||
|
|
|||||||||||||||
|
2019 |
2018 |
||||||||||||||
|
Dollars in |
Per diluted |
Dollars in |
Per diluted |
||||||||||||
|
millions |
share |
millions |
share |
||||||||||||
|
Net operating income (1) |
$ |
65.8 |
$ |
.41 |
$ |
73.9 |
$ |
.44 |
|||||||
|
Earnings on long-term care ceded block |
— |
— |
(8.2) |
(.05) |
|||||||||||
|
Net operating earnings, excluding the earnings on the long-term care ceded block |
65.8 |
.41 |
65.7 |
.39 |
|||||||||||
|
Significant items identified in prior year press release |
— |
— |
(.9) |
(.01) |
|||||||||||
|
Net operating earnings, excluding significant items and the earnings on the long-term care ceded block |
$ |
65.8 |
$ |
.41 |
$ |
64.8 |
$ |
.38 |
|||||||
In 3Q18, we ceded the Bankers Life legacy long-term care business under a 100% indemnity coinsurance agreement. In the above table, we have adjusted the operating earnings, excluding significant items, in 1Q18 to remove the earnings of this block.
There were no significant items in 1Q19. The significant items in 1Q18 included: (i) a
Non-Operating Items
Net realized investment losses in 1Q19 were
During 1Q19 and 1Q18, we recognized an increase (decrease) in earnings of
During 1Q19 and 1Q18, we recognized an increase (decrease) in earnings of
In 1Q19, we recognized a decrease in earnings of
Statutory (based on non-GAAP measures) and GAAP Capital Information
Our consolidated statutory risk-based capital ratio was estimated at 416% at
During the first quarter of 2019, we repurchased
Unrestricted cash and investments held by our holding company were
Book value per common share was
The debt-to-capital ratio was 19.3 percent and 21.4 percent at
Other Announcements
CNO also announced today that it has acquired privately-owned
Conference Call
The Company will host a conference call to discuss results on
About
|
|
|||||||
|
CONSOLIDATED BALANCE SHEET |
|||||||
|
(Dollars in millions) |
|||||||
|
(unaudited) |
|||||||
|
|
|
||||||
|
ASSETS |
|||||||
|
Investments: |
|||||||
|
Fixed maturities, available for sale, at fair value (amortized cost: March 31, 2019 - |
$ |
19,468.4 |
$ |
18,447.7 |
|||
|
Equity securities at fair value (cost: |
40.8 |
291.0 |
|||||
|
Mortgage loans |
1,626.1 |
1,602.1 |
|||||
|
Policy loans |
121.3 |
119.7 |
|||||
|
Trading securities |
237.9 |
233.1 |
|||||
|
Investments held by variable interest entities |
1,241.4 |
1,468.4 |
|||||
|
Other invested assets |
943.3 |
833.4 |
|||||
|
Total investments |
23,679.2 |
22,995.4 |
|||||
|
Cash and cash equivalents - unrestricted |
621.6 |
594.2 |
|||||
|
Cash and cash equivalents held by variable interest entities |
69.7 |
62.4 |
|||||
|
Accrued investment income |
214.8 |
205.2 |
|||||
|
Present value of future profits |
333.6 |
343.6 |
|||||
|
Deferred acquisition costs |
1,289.1 |
1,322.5 |
|||||
|
Reinsurance receivables |
4,879.7 |
4,925.4 |
|||||
|
Income tax assets, net |
479.9 |
630.0 |
|||||
|
Assets held in separate accounts |
4.9 |
4.4 |
|||||
|
Other assets |
741.9 |
356.7 |
|||||
|
Total assets |
$ |
32,314.4 |
$ |
31,439.8 |
|||
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|||||||
|
Liabilities: |
|||||||
|
Liabilities for insurance products: |
|||||||
|
Policyholder account balances |
$ |
11,658.2 |
$ |
11,594.1 |
|||
|
Future policy benefits |
11,252.9 |
11,082.4 |
|||||
|
Liability for policy and contract claims |
521.0 |
521.9 |
|||||
|
Unearned and advanced premiums |
255.9 |
253.9 |
|||||
|
Liabilities related to separate accounts |
4.9 |
4.4 |
|||||
|
Other liabilities |
804.0 |
632.4 |
|||||
|
Investment borrowings |
1,645.5 |
1,645.8 |
|||||
|
Borrowings related to variable interest entities |
1,416.8 |
1,417.2 |
|||||
|
Notes payable – direct corporate obligations |
917.3 |
916.8 |
|||||
|
Total liabilities |
28,476.5 |
28,068.9 |
|||||
|
Commitments and Contingencies |
|||||||
|
Shareholders' equity: |
|||||||
|
Common stock ( |
1.6 |
1.6 |
|||||
|
Additional paid-in capital |
2,952.2 |
2,995.0 |
|||||
|
Accumulated other comprehensive income |
654.9 |
177.7 |
|||||
|
Retained earnings |
229.2 |
196.6 |
|||||
|
Total shareholders' equity |
3,837.9 |
3,370.9 |
|||||
|
Total liabilities and shareholders' equity |
$ |
32,314.4 |
$ |
31,439.8 |
|||
|
|
|||||||
|
CONSOLIDATED STATEMENT OF OPERATIONS |
|||||||
|
(Dollars in millions, except per share data) |
|||||||
|
(unaudited) |
|||||||
|
Three months ended |
|||||||
|
|
|||||||
|
2019 |
2018 |
||||||
|
Revenues: |
|||||||
|
Insurance policy income |
$ |
619.3 |
$ |
659.9 |
|||
|
Net investment income: |
|||||||
|
General account assets |
270.6 |
329.1 |
|||||
|
Policyholder and other special-purpose portfolios |
85.2 |
12.8 |
|||||
|
Realized investment gains (losses): |
|||||||
|
Net realized investment gains (losses), excluding impairment losses |
18.3 |
(15.2) |
|||||
|
Impairment losses recognized (a) |
(2.2) |
— |
|||||
|
Total realized gains |
16.1 |
(15.2) |
|||||
|
Fee revenue and other income |
31.8 |
21.2 |
|||||
|
Total revenues |
1,023.0 |
1,007.8 |
|||||
|
Benefits and expenses: |
|||||||
|
Insurance policy benefits |
623.5 |
586.6 |
|||||
|
Interest expense |
41.0 |
33.6 |
|||||
|
Amortization |
58.2 |
71.9 |
|||||
|
Other operating costs and expenses |
234.7 |
207.6 |
|||||
|
Total benefits and expenses |
957.4 |
899.7 |
|||||
|
Income before income taxes |
65.6 |
108.1 |
|||||
|
Income tax expense on period income |
13.8 |
23.8 |
|||||
|
Net income |
$ |
51.8 |
$ |
84.3 |
|||
|
Earnings per common share: |
|||||||
|
Basic: |
|||||||
|
Weighted average shares outstanding |
160,948,000 |
167,060,000 |
|||||
|
Net income |
$ |
.32 |
$ |
.50 |
|||
|
Diluted: |
|||||||
|
Weighted average shares outstanding |
162,189,000 |
169,677,000 |
|||||
|
Net income |
$ |
.32 |
$ |
.50 |
|||
|
______________ |
|
|
(a) |
No portion of the other-than-temporary impairments recognized in the periods was included in accumulated other comprehensive income. |
|
|
|||||||
|
FIRST-YEAR COLLECTED PREMIUMS |
|||||||
|
(Dollars in millions) |
|||||||
|
Three months ended |
|||||||
|
|
|||||||
|
2019 |
2018 |
||||||
|
Bankers Life: |
|||||||
|
Medicare supplement |
$ |
14.3 |
$ |
15.4 |
|||
|
Long-term care |
4.4 |
3.7 |
|||||
|
Supplemental health |
1.1 |
1.1 |
|||||
|
Other health |
.2 |
.2 |
|||||
|
Life |
25.9 |
29.2 |
|||||
|
Annuity |
314.2 |
249.9 |
|||||
|
Total |
360.1 |
299.5 |
|||||
|
Washington National: |
|||||||
|
Supplemental health and other health |
16.7 |
18.4 |
|||||
|
Life |
1.9 |
1.3 |
|||||
|
Total |
18.6 |
19.7 |
|||||
|
Colonial Penn: |
|||||||
|
Life |
12.8 |
11.9 |
|||||
|
Total |
12.8 |
11.9 |
|||||
|
Total first-year collected premiums from segments |
$ |
391.5 |
$ |
331.1 |
|||
|
TOTAL COLLECTED PREMIUMS |
|||||||
|
(Dollars in millions) |
|||||||
|
Three months ended |
|||||||
|
|
|||||||
|
2019 |
2018 |
||||||
|
Bankers Life: |
|||||||
|
Medicare supplement |
$ |
184.0 |
$ |
188.3 |
|||
|
Long-term care |
63.8 |
64.8 |
|||||
|
Supplemental health |
6.0 |
5.8 |
|||||
|
Other health |
1.5 |
1.5 |
|||||
|
Life |
113.3 |
115.2 |
|||||
|
Annuity |
315.3 |
251.4 |
|||||
|
Total |
683.9 |
627.0 |
|||||
|
Washington National: |
|||||||
|
Supplemental health and other health |
157.0 |
155.7 |
|||||
|
Medicare supplement |
10.6 |
12.5 |
|||||
|
Life |
8.8 |
7.6 |
|||||
|
Annuity |
.4 |
.4 |
|||||
|
Total |
176.8 |
176.2 |
|||||
|
Colonial Penn: |
|||||||
|
Life |
76.8 |
74.8 |
|||||
|
Medicare supplement and other health |
.4 |
.5 |
|||||
|
Total |
77.2 |
75.3 |
|||||
|
Long-term care in run-off: |
|||||||
|
Long-term care |
3.6 |
49.6 |
|||||
|
Total |
3.6 |
49.6 |
|||||
|
Total collected premiums from segments |
$ |
941.5 |
$ |
928.1 |
|||
|
|
|||||||
|
NEW ANNUALIZED PREMIUMS FOR LIFE AND HEALTH PRODUCTS (4) |
|||||||
|
(Dollars in millions) |
|||||||
|
Three months ended |
|||||||
|
|
|||||||
|
2019 |
2018 |
||||||
|
Bankers Life: |
|||||||
|
Medicare supplement |
$ |
12.4 |
$ |
12.9 |
|||
|
Long-term care |
5.8 |
5.0 |
|||||
|
Supplemental health and other health |
1.2 |
1.3 |
|||||
|
Life |
14.1 |
16.5 |
|||||
|
Total |
33.5 |
35.7 |
|||||
|
Washington National: |
|||||||
|
Supplemental health |
20.7 |
22.0 |
|||||
|
Life |
3.2 |
1.8 |
|||||
|
Total |
23.9 |
23.8 |
|||||
|
Colonial Penn: |
|||||||
|
Life |
22.4 |
18.6 |
|||||
|
Total |
22.4 |
18.6 |
|||||
|
Total new annualized premiums |
$ |
79.8 |
$ |
78.1 |
|||
|
ANNUITY ACCOUNT VALUES |
|||||||
|
(Dollars in millions) |
|||||||
|
|
|||||||
|
2019 |
2018 |
||||||
|
Bankers Life |
$ |
8,688.6 |
$ |
8,221.2 |
|||
|
Washington National |
331.9 |
368.1 |
|||||
|
Total |
$ |
9,020.5 |
$ |
8,589.3 |
|||
|
BROKER DEALER AND REGISTERED INVESTMENT ADVISOR CLIENT ASSETS |
|||||||
|
(Dollars in millions) |
|||||||
|
Three months ended |
|||||||
|
|
|||||||
|
2019 |
2018 |
||||||
|
Net new client assets (a): |
|||||||
|
Brokerage |
$ |
(3.0) |
$ |
12.2 |
|||
|
Advisory |
35.7 |
50.5 |
|||||
|
Total |
$ |
32.7 |
$ |
62.7 |
|||
|
Client assets at end of period (b): |
|||||||
|
Brokerage |
$ |
861.6 |
$ |
806.7 |
|||
|
Advisory |
372.8 |
219.1 |
|||||
|
Total |
$ |
1,234.4 |
$ |
1,025.8 |
|||
|
(a) |
Net new client assets includes total inflows of cash and securities into brokerage and managed advisory accounts less outflows. Inflows include interest and dividends and exclude changes due to market fluctuations. |
|
(b) |
Client assets include cash and securities in brokerage and managed advisory accounts. |
|
Bankers Life is the marketing brand of various affiliated companies of |
|
|
Securities and variable annuity products and services are offered by |
|
|
Benefit Ratios On Major Health Lines Of Business |
|||||
|
Three months ended |
|||||
|
|
|||||
|
2019 |
2018 |
||||
|
Bankers Life: |
|||||
|
Medicare supplement: |
|||||
|
Earned premium |
|
|
|||
|
Benefit ratio (5) |
72.3% |
73.3% |
|||
|
Long-term care: |
|||||
|
Earned premium |
|
|
|||
|
Benefit ratio (5) |
120.6% |
116.3% |
|||
|
Interest-adjusted benefit ratio (a non-GAAP measure) (6) |
77.2% |
73.9% |
|||
|
Washington National: |
|||||
|
Supplemental health: |
|||||
|
Earned premium |
|
|
|||
|
Benefit ratio (5) |
77.6% |
78.3% |
|||
|
Interest-adjusted benefit ratio (a non-GAAP measure) (6) |
53.4% |
54.4% |
|||
|
NOTES |
|
|
(1) |
Management believes that an analysis of Net income applicable to common stock before: (i) net realized investment gains or losses from sales and impairments, net of related amortization and taxes; (ii) net change in market value of investments recognized in earnings, net of taxes; (iii) fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, net of related amortization and taxes; (iv) fair value changes related to the agent deferred compensation plan, net of taxes; (v) loss related to reinsurance transaction, net of taxes; (vi) changes in the valuation allowance for deferred tax assets and other tax items; and (vii) other non-operating items consisting primarily of earnings attributable to variable interest entities, net of taxes ("Net operating income," a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the company's underlying fundamentals. A reconciliation of Net operating income to Net income applicable to common stock is provided in the table on page 2. Additional information concerning this non-GAAP measure is included in our periodic filings with the |
|
(2) |
Book value per diluted share reflects the potential dilution that could occur if outstanding stock options were exercised, restricted stock and performance units were vested and convertible securities were converted. The dilution from options, restricted shares and performance units is calculated using the treasury stock method. Under this method, we assume the proceeds from the exercise of the options (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the closing market price on the last day of the period. The dilution from convertible securities is calculated assuming the securities were converted on the last day of the period. In addition, the calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments. |
|
(3) |
The calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments. |
|
(4) |
Measured by new annualized premium for life and health products, which includes 10% of single premium whole life deposits and 100% of all other premiums (excluding annuities). Medicare Advantage sales are not comparable to other sales and are therefore excluded in all periods. |
|
(5) |
The benefit ratio is calculated by dividing the related product's insurance policy benefits by insurance policy income. |
|
(6) |
The interest-adjusted benefit ratio (a non-GAAP measure) is calculated by dividing the product's insurance policy benefits less imputed interest income on the accumulated assets backing the insurance liabilities by insurance policy income. Interest income is an important factor in measuring the performance of longer duration health products. The net cash flows generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases), which will be paid out as benefits in later policy years (accounted for as reserve decreases). Accordingly, as the policies age, the benefit ratio will typically increase, but the increase in the change in reserve will be partially offset by the imputed interest income earned on the accumulated assets. The interest-adjusted benefit ratio reflects the effects of such interest income offset (which is equal to the tabular interest on the related insurance liabilities). Since interest income is an important factor in measuring the performance of these products, management believes a benefit ratio, which includes the effect of interest income, is useful in analyzing product performance. Additional information concerning this non-GAAP measure is included in our periodic filings with the |
Cautionary Statement Regarding Forward-Looking Statements. Our statements, trend analyses and other information contained in this press release relative to markets for
View original content:http://www.prnewswire.com/news-releases/cno-financial-group-reports-first-quarter-2019-results-300840107.html
SOURCE


Tenet Reports Results for the First Quarter Ended March 31, 2019
Kingstone Announces 2019 First Quarter Catastrophe Losses and Reorganization of Claims Department
Advisor News
- Demonstrating the value of life insurance to Gen Z
- Poor money habits are a dealbreaker in a new relationship
- DC plan sponsors see opportunity in alternatives
- The American Dream: Redefined as financial stability
- Partial annuitization: How advisors can help clients balance income, growth
More Advisor NewsAnnuity News
- CA judge certifies class action in teachers’ lawsuit over in-plan annuity fees
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Managing Director Joins ‘Target Topics’ Podcast to Discuss State of Delegated Underwriting Authority Enterprises Market
- KBRA Assigns Rating to TruSpire Retirement Insurance Company
- Partial annuitization: How advisors can help clients balance income, growth
More Annuity NewsHealth/Employee Benefits News
- Copay assistance is meant to defray patient drug costs. Some insurers keep it instead
- Amid claims of 'playing politics,' Auburn council amends city manager's contract
- OCWNY to hold seminar for disability beneficiaries Friday
- Atrium pushes back after State Health Plan leaves healthcare network out of Tier 1
- Douglas Veterans Claims Clinic Connects Rural Veterans With Critical Services
More Health/Employee Benefits NewsLife Insurance News
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Upgrades Credit Ratings of Sagicor Financial Company Ltd. and Most of Its Subsidiaries
- Trust, technology and the future of claims
- New York Life Launches an Indemnity Benefit for its Asset Flex Long-Term Care Insurance Solution
- AM Best Affirms Credit Ratings of DB Insurance Co., Ltd.
More Life Insurance News